Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharm to lay off a quarter of workforce, suspends dividend
Israel's Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Exclusive: Teva poised to raise its stake in Mylan - sources
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits - CNN
Teva buys Anda for $500 million - ISRAEL21c
Florida Reaches $878 Million Opioid Settlements With CVS, Teva, Others
Teva settles shareholder lawsuit over generic drug | Business Insurance
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
US Supreme Court sides with Teva in drug dispute
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AP6KIV5ZJZMMXHJ3TT4TTMV3MQ.jpg "Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters")
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | Fierce Pharma
TEVA.TA - Teva Pharmaceutical Industries Limited | Stock Price & Latest News | Reuters
Teva in talks with Covid-19 vaccine manufacturers to co-produce shots | Ctech
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LZGVDDQWGFNKPLS2GEX4W3DBA4.jpg "Teva lied about opioid role, New York says | Reuters")
Teva lied about opioid role, New York says | Reuters
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva stock plummets 18% after rough quarter in US generic drug market
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
/s3.amazonaws.com/arc-authors/reuters/e2e84f39-06fb-4823-be96-9e32685d8ce7.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
